<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>RALP1 Is Rhoptry Neck Erythrocyte-Binding Protein <span id='am-37' about='obo:NCBITaxon_5820' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-38' property="rdfs:label" content="Plasmodium" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-40'  ></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Plasmodium</span> <br /> falciparum Merozoites Potential Blood-Stage Vaccine Candidate <br /> Antigen <br /> Daisuke Ito,a Tomoyuki Hasegawa,a Kazutoyo Miura,b Tsutomu Yamasaki,a* Thangavelu U. Arumugam,a Amporn Thongkukiatkul,c <br /> Satoru Takeo,a* Eizo Takashima,a Jetsumon Sattabongkot,d Eun-Taek Han,e Carole A. Long,b Motomi Torii,f Takafumi Tsuboia,g <br /> Division Malaria Research, Proteo-Science Center,a Venture Business Laboratory,g Ehime University, Matsuyama, Ehime, Japan; Laboratory Malaria Vector <br /> Research, National Institute Allergy Infectious Diseases, National Institutes Health, Rockville, Maryland, USAb; Department Biology, Faculty Science, Burapha <br /> University, Chonburi, Thailandc; Mahidol Vivax Research Unit, Faculty Tropical Medicine, Mahidol University, Bangkok, Thailandd; Department Medical Environmental <br /> Biology Tropical Medicine, School Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic Koreae; Division Molecular Parasitology, <br /> Proteo-Science Center, Ehime University, Shitsukawa, Toon, Ehime, Japanf <br />  <br /> Erythrocyte invasion merozoites obligatory stage Plasmodium infection essential disease progression. Pro- <br /> teins apical organelles merozoites mediate invasion erythrocytes potential malaria vaccine candidates. <br /> Rhoptry-associated, leucine zipper-like protein 1 (RALP1) <span id='am-53' about='obo:NCBITaxon_5833' typeof='obo:NCBITaxon_5820 owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_418107 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-54' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="malaria parasite P. falciparum" datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="Plasmodium falciparum" datatype="xsd:string"></span><span id='am-57'  ></span><span id='am-58' property="oboInOwl:hasRelatedSynonym" content="Plasmodium (Laverania) falciparum" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Plasmodium falciparum</span> previously specifically <br /> expressed schizont stages localized rhoptries merozoites immunofluorescence assay (IFA). Also, RALP1 has <br /> been refractory gene knockout attempts, suggesting essential blood-stage parasite survival. These characteristics <br /> suggest RALP1 potential blood-stage vaccine candidate antigen, assessed potential regard. <br /> Antibodies raised recombinant RALP1 proteins synthesized using wheat germ cell-free system. Immunoelec- <br /> tron microscopy demonstrated time RALP1 rhoptry neck protein merozoites. Moreover, IFA <span id='am-121' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-122' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-123'  ></span><span id='am-124' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-125' property="rdfs:label" content="Data" datatype="xsd:string"></span>data</span> <br /> showed RALP1 translocates rhoptry neck moving junction merozoite invasion. Growth invasion <br /> inhibition assays revealed anti-RALP1 antibodies inhibit invasion erythrocytes merozoites. The findings that <br /> RALP1 possesses erythrocyte-binding epitope C-terminal region anti-RALP1 antibodies disrupt tight-junction <br /> formation, evidence RALP1 plays important role merozoite invasion erythrocytes. In addition, human sera <br /> collected areas Thailand Mali malaria endemic recognized protein. Overall, findings indicate that <br /> RALP1 rhoptry neck erythrocyte-binding protein qualifies potential blood-stage vaccine candidate. <br />  <br />  <br />  <br />  <br /> P   lasmodium falciparum virulent malaria parasite of <br />     <span id='am-80' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-81' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-82' property="rdfs:label" content="species" datatype="xsd:string"></span>species</span> infecting humans, affecting 216 million <br /> individuals killing 0.7 million individuals 2010 <br />                                                                                         parasitophorous vacuole (PV). After attachment merozoites to <br />                                                                                         erythrocytes, rhoptry proteins mediate direct high-affinity mero- <br />                                                                                         zoite-erythrocyte interactions micronemal proteins (7) that <br /> worldwide (1). Since half 1950s, appearance                    ultimately lead tight-junction formation irreversible com- <br /> malaria parasites resistance antimalarial drugs mos-                     mitment merozoite invasion. The tight junction char- <br /> quito <span id='am-93' about='obo:NCBITaxon_29278' typeof='owl:Thing obo:NCBITaxon_81077 obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-94' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-96' property="rdfs:label" content="vectors" datatype="xsd:string"></span>vectors</span> resistance insecticides highlighted                       acterized <span id='am-97' about='obo:NCBITaxon_1118549' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_8936 obo:NCBITaxon_1329799 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_436489 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_57387 obo:NCBITaxon_33154 obo:NCBITaxon_8782 obo:NCBITaxon_436486 obo:NCBITaxon_1338369 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_8492 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_8825 obo:NCBITaxon_7776 obo:NCBITaxon_436492 obo:NCBITaxon_32561 obo:NCBITaxon_8457 obo:NCBITaxon_436491'><span id='am-98' property="rdfs:label" content="Electron" datatype="xsd:string"></span><span id='am-99' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-100' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-101'  ></span>electron</span>-dense thickening erythrocyte <br /> importance malaria vaccine development. Although number                            membrane merozoite, molecular makeup yet <br /> of vaccine candidates developed tested preclini-                       fully understood, known include number of <br /> cal clinical trials, limited clinical success                         rhoptry neck proteins (RONs), micronemal protein <br /> achieved vaccines date (2, 3). Therefore, discovery novel                    AMA1 (8, 9). On hand, proteins belonging the <br /> vaccine candidates currently important step                        reticulocyte-binding-like homologue (Rh) protein <span id='am-29' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-30' property="rdfs:label" content="family" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>family</span>, located <br /> renewed focus control, local elimination, eventual global                        rhoptries, shown translocate bind eryth- <br /> eradication efforts (4). <br />     The symptoms malaria caused blood-stage cyclic in- <br /> fection subsequent rupture host&#8217;s erythrocytes obli-                          Received 1 June 2013 Returned modification 10 July 2013 <br />                                                                                             Accepted 29 August 2013 <br /> gate asexual intracellular malaria parasites. Erythrocyte invasion <br />                                                                                             Published ahead print 3 September 2013 <br /> by merozoite, invasive form blood-stage parasite <br />                                                                                             Editor: J. H. Adams <br /> exposed human immunity, mediated complex set of <br />                                                                                             Address correspondence Takafumi Tsuboi, tsuboi@ccr.ehime-u.ac.jp. <br /> interactions different parasite ligands erythrocyte re- <br />                                                                                             * Present address: Tsutomu Yamasaki, Department Life Science, Faculty of <br /> ceptors (5&#8211;7). The ligands used merozoite invasion <br />                                                                                             Science, Okayama University Science, Okayama, Japan; Satoru Takeo, Division of <br /> are expressed surface merozoite discharged                          Tropical Diseases Parasitology, Department Infectious Diseases, Faculty of <br /> from specialized apical organelles (rhoptries, micronemes,                              Medicine, Kyorin University, Mitaka, Tokyo, Japan. <br /> dense granules) (5&#8211;7). Among apical organelles, rhoptries                           Supplemental material article http://dx.doi.org/10.1128 <br /> the prominent large secretory organelles present pairs                           /IAI.00690-13. <br /> the apical tip merozoite contents thought                        Copyright &#169; 2013, American Society Microbiology. All Rights Reserved. <br /> important invasion processes, initial host                           doi:10.1128/IAI.00690-13 <br /> cell sensing, tight-junction formation, establishment the <br />  <br />  <br /> 4290   iai.asm.org                                    Infection Immunity    p. 4290 &#8211; 4298                                      November 2013 Volume 81 Number 11 <br />                                                                                                      P. falciparum RALP1, Potential Malaria Vaccine Candidate <br />  <br />  <br />  <br /> rocytes, leading tight-junction formation, play di-             region RALP1, encompassing 396 <span id='am-102' about='obo:NCBITaxon_152839' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4447 obo:NCBITaxon_4747 obo:NCBITaxon_158359 obo:NCBITaxon_158331 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_158350 obo:NCBITaxon_73496 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_1437197 obo:NCBITaxon_3193'><span id='am-103' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-104' property="oboInOwl:hasRelatedSynonym" content="Aa Rchb.f." datatype="xsd:string"></span><span id='am-105' property="rdfs:label" content="Aa" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-107'  ></span>aa</span> [F17 Q412]), RALP1-C1 (C- <br /> rect role invasion (10). In way, rhoptry proteins                terminal region RALP1, encompassing 239 aa [N396 P634]), and <br /> represent promising blood-stage P. falciparum vaccine candidates.              RALP1-C2 (C-terminal region RALP1, encompassing 315 aa [N396 to <br /> Therefore, study taken objective character-            K710]) amplified P. falciparum 3D7 genomic DNA PCR by <br /> izing P. falciparum rhoptry proteins assessing novel               using sense primers XhoI sites antisense primers BamHI <br /> blood-stage vaccine candidates.                                                restriction sites (in lowercase letters primer sequences below). <br />     Previous bioinformatic searches using transcriptional                  Primers RALP1-N1-F (5=-ctcgagATGCCACTTCAACGTGGCGCATC- <br />                                                                                3=) RALP1-N1-R (5=-ggatccCTAGTGATGATGATGATGATGATCA <br /> structural features known proteins Haase et al. (11) have <br />                                                                                ACGTTCACATTCATTTGTTGATT-3=), primers RALP1-N2-F (5=-ctcga <br /> identified hypothetical proteins probably located on <br />                                                                                gTTTTACCTGATAAAGTCATCTTCCAAT-3=) RALP1-N2-R (5=-g <br /> the surface merozoite secretory organelles. Of                gatccCTATTGATCATTCATCAATTTTACAAAAAC-3=), primers <br /> these candidates, experimentally shown                        RALP1-C1-F (5=-ctcgagAATGGTAAGAAGGATAAAAATGGGGT-3=) <br /> PF3D7_0722200 appears localized rhoptry P.                     RALP1-C1-R (5=-ggatccCTATGGTACATTTTTAGGTGTAAAAGT <br /> falciparum merozoites possess leucine zipper-like do-                 AGT-3=), primers RALP1-C2-F (5=-ctcgagAATGGTAAGAAGGATA <br /> main, structural feature facilitates protein-protein inter-             AAAATGGGGT-3=) RALP1-C2-R (5=-ggatccCTATTTGTTTCCCA <br /> action, designated rhoptry-associated leucine zip-                TATCATTTTTATTATATTT-3=) used generate DNA <br /> per-like protein 1 (RALP1). Furthermore, RALP1 conserved                 fragments encoding RALP1-N1, -N2, -C1, -C2 proteins, respec- <br /> Plasmodium spp. refractory gene knockout attempts (11),           tively. The underlined sequences primer RALP1-N1-R indicate re- <br /> suggesting RALP1 play important role invasion.                gions encode hexahistidine tag. <br /> However, far, studies attempted growth and/or invasion                  The amplified fragments restricted ligated the <br /> inhibition assays antibodies raised recombinant RALP1             wheat germ cell-free expression vectors (CellFree Sciences). The fragment <br /> proteins; therefore, RALP1 characterized vaccine            encoding RALP1-N1 cloned pEU-E01-MCS vector. Frag- <br /> candidate. In study, attempted test RALP1              ments encoding RALP1-N2, -C1, -C2 cloned pEU-E01- <br />                                                                                GST-TEV-N2 vector. The cloned inserts sequenced ABI <br /> potential blood-stage vaccine candidate. In regard, expressed <br />                                                                                PRISM 3100-Avant genetic analyzer (Applied Biosystems, Foster City, <br /> recombinant RALP1 using wheat germ cell-free system, de-                CA). The recombinant proteins His glutathione S-trans- <br /> fined subcellular localization RALP1 immunoelectron mi-              ferase (GST) tag expressed wheat germ cell-free and <br /> croscopy (IEM), tested growth and/or invasion inhibition activity          purified nickel-Sepharose column (GE Healthcare) the <br /> of anti-RALP1 antibodies, analyzed reactivity malaria im-           case RALP1-C1 glutathione-Sepharose 4B column (GE Health- <br /> mune human sera RALP1.                                                      care). GST-tagged RALP1-N2 purified glutathione elution. In the <br />                                                                                case GST-tagged RALP1-C1 -C2 proteins, N-terminal GST <br /> MATERIALS AND METHODS                                                          tag removed eluting GST-tagged RALP1 bound glutathione- <br /> Parasite culture free-merozoite purification. P. falciparum asexual        Sepharose 4B column using <span id='am-1' about='obo:NCBITaxon_12227' typeof='obo:NCBITaxon_12195 owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_10239 obo:NCBITaxon_439488 obo:NCBITaxon_35278 obo:NCBITaxon_39729'><span id='am-2'  ></span><span id='am-3' property="oboInOwl:hasRelatedSynonym" content="tobacco etch potyvirus" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasBroadSynonym" content="TEV" datatype="xsd:string"></span><span id='am-7' property="rdfs:label" content="Tobacco etch virus" datatype="xsd:string"></span>tobacco etch virus</span> (TEV) protease, which <br /> stages (strain 3D7A National Institute Allergy Infectious      cleaves TEV recognition site GST tag RALP1 <br /> Diseases [NIAID], NIH) maintained vitro erythrocytes           fragment. All detailed methods used wheat germ cell-free pro- <br /> healthy human donors (blood group O&#11001;) obtained Japanese Red           tein synthesis affinity purification described previously (16). <br /> Cross Society described (12). To harvest parasite pellets, ma-        To generate antisera protein (RALP1-N1, -C1, -C2), <br /> ture schizonts purified differential centrifugation 70%/40%       BALB/c mice immunized subcutaneously 20 &#65533;?&#65533;g purified <br /> Percoll-sorbitol gradient treated tetanolysin (List Biolog-   recombinant protein emulsified Freund&#8217;s complete adjuvant, fol- <br /> ical Laboratories, Inc., Campbell, CA) remove hemoglobin loss       lowed 20 &#65533;?&#65533;g protein Freund&#8217;s incomplete adjuvant. A <br /> of parasite proteins present PV space (13), washed phosphate-      Japanese white rabbit immunized subcutaneously 250 &#65533;?&#65533;g of <br /> buffered saline (PBS) containing Complete protease inhibitor (Roche,           purified protein Freund&#8217;s complete adjuvant, followed 250 &#65533;?&#65533;g of <br /> Mannheim, Germany), stored &#11002;80&#176;C used. The viable free            purified protein Freund&#8217;s incomplete adjuvant. All immunizations <br /> merozoites retain invasive capacity purified basis   times 3-week intervals, antisera collected <br /> the recently reported protocol (14). Briefly, parasites synchronized <br />                                                                                14 days immunization. All animal experimental pro- <br /> by using sorbitol treatment heparin (Mochida Pharmaceutical Co., <br />                                                                                tocols approved Institutional Animal Care Use Commit- <br /> Tokyo, Japan). Late-stage parasites (32 36 h postinvasion) purified <br />                                                                                tee Ehime University (su-14-6), experiments conducted <br /> (&#11022;95% purity) magnetic separation MACS CS column con- <br />                                                                                according Ethical Guidelines Animal Experiments Ehime <br /> junction VarioMACS magnetic separator (Miltenyi Biotec, Cam- <br />                                                                                University. In similar manner, mouse anti-RAP1 (M1 D782 3D7 <br /> bridge, MA), incubated 10 &#65533;?&#65533;M E64 (Sigma-Aldrich Corporation, St. <br /> Louis, MO) 6 8 h, pelleted. Resulting E64-treated schizonts    sequence [PF3D7_1410400]) antibody, mouse rabbit anti-AMA1 <br /> resuspended small volume incomplete culture medium (contain-           (Q25 K546 3D7 sequence [PF3D7_1133400]) antibodies, and <br /> ing protein component) filtered 1.2-&#65533;?&#65533;m Acrodisc               rabbit anti-GST antibody generated previously described (17). <br /> 32-mm syringe filter (Pall Corporation, Port Washington, NY).                  Mouse anti-RON4 monoclonal antibody (26C64F12) (8) kind gift <br />     Production recombinant proteins antisera. Genomic DNA               Jean F. Dubremetz (Universit&#233; Montpellier 2, Montpellier, <br /> was extracted P. falciparum strain 3D7A DNAzol reagent           France). <br /> (Invitrogen, Carlsbad, CA). The nucleotide sequence ralp1 gene              In <span id='am-90' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-91' property="rdfs:label" content="order" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>order</span> obtain antigen-specific IgGs, rabbit antisera RALP1 <br /> (PF3D7_0722200) strain 3D7 obtained malaria genome             proteins affinity purified columns conjugated respective <br /> database PlasmoDB (http://plasmodb.org). In order generate specific         recombinant RALP1 proteins ligands. Briefly, recombinant RALP1 <br /> antibodies, truncated regions ralp1 gene amplified ex-         proteins covalently linked HiTrap NHS-Activated HP columns <br /> pressed recombinant proteins wheat germ cell-free translation      (GE Healthcare) accordance manufacturer&#8217;s recommenda- <br /> system (CellFree Sciences, Matsuyama, Japan) described previously           tions. Rabbit antisera applied RALP1 protein-conjugated <br /> (15). Briefly, PF3D7_0722200 fragments encoding RALP1-N1 (N-               column. After extensive washing 20 mM phosphate buffer (pH 7.0), <br /> terminal region RALP1, encompassing 114 amino acids [aa; M35             antigen-specific IgGs eluted 0.1 M <span id='am-18' about='obo:NCBITaxon_3846' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_163735 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-19' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-21'  ></span><span id='am-22' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>glycine</span>-HCl, pH 2.5, and <br /> D148] hexahistidine tag C terminus), RALP1-N2 (N-terminal         immediately neutralized 1 M Tris, pH 9.0. <br />  <br />  <br /> November 2013 Volume 81 Number 11                                                                                                           iai.asm.org 4291 <br />  Ito et al. <br />  <br />  <br />  <br />      Preparation parasite schizont extract Western blot analysis.       flow cytometry described previously (19). Briefly, parasite cultures <br /> Purified, schizont-rich parasite pellets lysed appropriate          synchronized day start GIA, majority <br /> amount reducing SDS-PAGE sample buffer incubated 98&#176;C           parasites late trophozoite-to-schizont stage start the <br /> for 3 min. The lysate centrifuged 10,000 &#11003; g 10 min room         GIA. Twenty microliters parasite-infected erythrocyte (pRBC) suspen- <br /> temperature (RT), supernatants subjected electrophoresis        sion (0.3% parasitemia 2% hematocrit) 20 &#65533;?&#65533;l IgGs added <br /> a 12.5% polyacrylamide gel (ATTO, Tokyo, Japan). Proteins            half-area flat-bottom 96-well cell culture microplates (Corn- <br /> transferred 0.2-&#65533;?&#65533;m polyvinylidene difluoride membrane (Hybond             ing, Corning, NY) gently mixed. For control, 20 &#65533;?&#65533;l culture me- <br /> LFP; GE Healthcare) semidry blotting (ATTO). The mem-            dium added pRBC suspension. Cultures incubated 37&#176;C <br /> branes blocked PBS-MT (PBS containing 5% [wt/vol] nonfat             humidified, gassed (90% N2, 5% O2, 5% CO2), airtight boxes. After <br /> milk 0.1% [vol/vol] Tween 20), lanes cut strips. Then        25 h incubation, invading parasites developed to <br /> each membrane strip immunostained antiserum RT 1          early trophozoite stage, pRBC pelleted brief centrifugation <br /> h, followed horseradish peroxidase-conjugated secondary-antibody            (1,300 &#11003; g 5 min) washed 100 &#65533;?&#65533;l PBS. The cells then <br /> (GE Healthcare) probing, visualized Immobilon Western                 incubated 50 &#65533;?&#65533;l diluted (1:1,000 PBS) SYBR green I (Invitro- <br /> chemiluminescent horseradish peroxidase substrate (Millipore, Billerica,       gen) 10 min RT washed PBS. Parasitemia measured <br /> MA) LAS 4000 Mini luminescent-image analyzer (GE Healthcare).             flow cytometry FACSCanto II (BD Biosciences, San Jose, CA) by <br /> The relative molecular masses proteins estimated refer-       acquisition 50,000 events sample. Data analyzed with <br /> ence Precision Plus protein standards (Bio-Rad, Hercules, CA).              FlowJo 9.1 software (Tree Star, Ashley, OR) gating intact eryth- <br />      Imaging schizont merozoite invasion indirect immuno-            rocytes scatter forward scatter parameters subsequently <br /> fluorescence assay (IFA). Thin smears schizont-enriched P. falcipa-         determining proportion SYBR green I-positive cells. Samples were <br /> rum-infected erythrocytes prepared glass slides stored          tested triplicate experiment, independent experi- <br /> &#11002;80&#176;C. The smears thawed, fixed 4% paraformaldehyde RT            ments performed. <br /> for 10 min, permeabilized PBS-T (PBS containing 0.1% Triton                   The human IgGs purified serum samples Mali also <br /> X-100) RT 15 min, blocked PBS containing 5% nonfat milk        tested parasite invasion growth-inhibitory activity cycle <br /> (blocking solution) 37&#176;C 30 min.                                        parasite replication GIA Reference Center, NIAID, NIH. The GIA <br />      Free merozoites isolated described above, added uninfected     reaction mixture incubated 40 h presence test IgG allow <br /> erythrocytes, processed invasion described previously (14).         invading parasites develop schizont stage, then <br /> Invading merozoites collected 2 10 min incubation        parasite growth determined biochemical assay specific para- <br /> erythrocytes shaker 37&#176;C, fixed RT 30 min 4% parafor-      site lactate dehydrogenase previously described (20). <br /> maldehyde&#8211; 0.0075% glutaraldehyde PBS, permeabilized PBS-T              Immunoprecipitation. Immunoprecipitation carried pre- <br /> RT 15 min, blocked PBS containing 3% bovine serum albumin             viously described (17). Briefly, proteins extracted late schizont <br /> (BSA) 37&#176;C 30 min, applied polyethyleneimine-coated         parasite pellets PBS 1% Triton X-100 containing Complete pro- <br /> coverslips.                                                                    tease inhibitor. Fifty-microliter samples supernatants preincu- <br />      The antigen samples IFA described stained pri-        bated 4&#176;C 1 h 40 &#65533;?&#65533;l 50% protein G-conjugated beads (pro- <br /> mary antibodies diluted following concentrations blocking solu-      tein G-Sepharose 4 Fast Flow; GE Healthcare) NETT buffer (50 mM <br /> tion 37&#176;C 1 h: rabbit anti-RALP1-C1 antibody, 1:500; rabbit anti-       Tris-HCl, 0.15 M NaCl, 1 mM EDTA, 0.5% Triton X-100) supplemented <br /> RALP1-C2 antibody, 1:500; mouse anti-RALP1-N1 antibody, 1:100;                 0.5% BSA (fraction V; Sigma-Aldrich Corporation). Aliquots re- <br /> mouse anti-RAP1 antibody, 1:100 (17); mouse anti-RON4 monoclonal               covered supernatants incubated rabbit anti-RALP1-N1, anti- <br /> antibody, 1:1,000 (gift Jean F. Dubremetz). Secondary antibodies,         RALP1-C1, anti-AMA1, anti-GST antibody, 40 &#65533;?&#65533;l 50% <br /> <span id='am-8' about='obo:NCBITaxon_149625' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_163739 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-9' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-10'  ></span><span id='am-11' property="rdfs:label" content="Alexa" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Alexa</span> Fluor 488-conjugated goat anti-rabbit IgG Alexa Fluor 568-           protein G-conjugated bead suspension added. After incubation 1 <br /> conjugated goat anti-mouse IgG (Invitrogen), used 1:500 dilu-        h 4&#176;C, beads washed NETT&#8211; 0.5% BSA, with <br /> tion blocking solution 37&#176;C 30 min. DAPI (4=,6-diamidino-2-          NETT, high-salt (0.5 M NaCl) NETT, NETT, and <br /> phenylindole) 2 &#65533;?&#65533;g/ml added secondary-antibody              low-salt (0.05 M NaCl, 0.17% Triton X-100) NETT. Finally, <br /> solution stain nuclei. Slides mounted ProLong Gold Anti-        proteins extracted protein G-conjugated beads incuba- <br /> fade reagent (Invitrogen) viewed 63&#11003; oil immersion <span id='am-23' about='obo:NCBITaxon_3863' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_163743 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-24' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-25'  ></span><span id='am-26' property="oboInOwl:hasRelatedSynonym" content="Lens Mill." datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="Lens" datatype="xsd:string"></span>lens</span>.           tion 1&#11003; SDS-PAGE reducing loading buffer 98&#176;C 3 min. The <br /> High-resolution image capture processing performed             supernatants used Western blot analysis. <br /> confocal scanning <span id='am-116' about='obo:NCBITaxon_62990' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_364270 obo:NCBITaxon_131567 obo:NCBITaxon_241799 obo:NCBITaxon_91882 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_241789 obo:NCBITaxon_4037 obo:NCBITaxon_241778 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_4036 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71274 obo:NCBITaxon_3193'><span id='am-117' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-118'  ></span><span id='am-119' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-120' property="rdfs:label" content="Laser" datatype="xsd:string"></span>laser</span> microscope (LSM710; Carl Zeiss MicroImaging,               FACS-based EBA. An assay checking erythrocyte-binding ac- <br /> Thornwood, NY). Images processed Adobe Photoshop (Adobe                tivity RALP1 basis protocol used assay the <br /> Systems Inc., San Jose, CA).                                                   erythrocyte-binding activity Duffy antigen (21). Rh5 P. falciparum is <br />      IEM. Parasites fixed embedded LR White resin (Poly-           unique erythrocyte-binding proteins de- <br /> sciences, Inc., Warrington, PA) previously described (18). Ultrathin        leted P. falciparum strain. Both native recombinant Rh5 <br /> sections immunostained previously described (19). Samples         previously shown bind erythrocytes (22). Therefore, used <br /> examined transmission electron microscope (JEM-1230; JEOL,              Rh5 universal positive-control protein erythrocyte-binding as- <br /> Tokyo, Japan).                                                                 say (EBA). In brief, GST-tagged RALP1-N2, RALP1-C1, full-length Rh5 <br />      GIAs. Total rabbit IgGs growth inhibition assays (GIAs) pu-      (comprising aa E26 Q526 3D7 sequence [PF3D7_0424100] with- <br /> rified rabbit antisera HiTrap protein G-Sepharose columns (GE        signal peptide), GST (negative control) synthesized by <br /> Healthcare) according manufacturer&#8217;s protocol. Purified IgGs       wheat germ cell-free purified glutathione-Sepharose <br /> further buffer exchanged incomplete culture medium, concentrated          column chromatography glutathione elution described above. <br /> with Amicon Ultra-15 centrifugal filter units (Millipore), filter sterilized   Erythrocytes washed times PBS&#8211;1% BSA, resuspended to <br /> with Ultrafree-MC GV 0.22-&#65533;?&#65533;m centrifugal filter (Millipore), pre-       1 &#11003; 105 cells 200 &#65533;?&#65533;l PBS&#8211;1% BSA, preincubated 20 &#65533;?&#65533;g <br /> absorbed remove nonspecific antierythrocyte antibodies 25 &#65533;?&#65533;l        recombinant protein RT 3 h. After preincubation, erythrocytes were <br /> packed human O&#11001; erythrocytes purified IgG 1 ml antiserum           washed PBS incubated fluorescein isothiocyanate <br /> at RT 1 h rotating wheel. Finally, concentrations rabbit   (FITC)-conjugated anti-GST antibody (1:100 PBS 1% BSA; Ab- <br /> IgG samples adjusted 40 mg/ml incomplete culture medium.            cam, Cambridge, United <span id='am-113' about='obo:NCBITaxon_kingdom' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-114' property="rdfs:label" content="kingdom" datatype="xsd:string"></span><span id='am-115' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Kingdom</span>) RT 1 h protected from <br />      The inhibitory activity rabbit IgGs merozoite invasion tested   light. Erythrocytes washed PBS once, resuspended 200 &#65533;?&#65533;l of <br /> over cycle parasite replication, parasitemia determined      PBS, transferred fluorescence-activated cell sorter (FACS) tubes. A <br />  <br />  <br /> 4292     iai.asm.org                                                                                                                   Infection Immunity <br />                                                                                                   P. falciparum RALP1, Potential Malaria Vaccine Candidate <br />  <br />  <br />  <br /> total 50,000 erythrocytes read FACSCanto II flow cytometer,      teins. The N1, C1, C2 truncated proteins used immu- <br /> and resulting flow cytometry data analyzed FlowJo software.     nize rabbits mice produce antibodies. <br /> The percentage erythrocytes bound recombinant RALP1 (%                 RALP1 expression analyzed RALP1-specific antibod- <br /> cells) obtained percentage erythrocytes positive       ies Western blot assay protein extracts synchronized <br /> FITC signal background FITC measurement erythrocytes             schizont-rich parasites. All antisera raised N1, <br /> without recombinant protein. <br />                                                                               C1, C2 truncated forms RALP1 recognized protein of <br />     IFA-based MIBA. Total IgGs tested merozoite invasion- <br /> blocking assay (MIBA) purified rabbit antisera described         &#11022;90 kDa protein extracts P. falciparum parasites schi- <br /> above. To filtered merozoites, antibodies added final con-      zont stages (Fig. 1C, arrowhead), corresponding predicted <br /> centration 20 mg/ml total IgG anti-RALP1-C1 anti-GST serum        molecular mass 88 kDa. Additionally, anti-RALP1-N1 both <br /> (diluted incomplete culture medium) uninfected erythrocytes            anti-RALP1-C1 anti-RALP1-C2 antisera recognized distinct <br /> (50% hematocrit; 10 &#65533;?&#65533;l) incubated 37&#176;C 10 min. Control assays      53- 50-kDa proteins, respectively, represent processed N- <br /> were performed incomplete culture medium. After fixation             C-terminal forms RALP1 protein (Fig. 1C, asterisks). In <br /> washing, samples processed IFA DAPI mouse anti-             case anti-RALP1-C1 -C2 antiserum staining, faint <br /> RAP1 antibody described above. For condition, biological        band 40 kDa visible, suggesting processing <br /> replicates approximately 2,000 erythrocytes attached invading      event C-terminal region RALP1. The negative-control <br /> parasites scored confocal scanning laser microscope. <br />                                                                               lane stained secondary antibody showed signal <br />     ELISAs. Human serum samples western Thailand collected <br /> from asymptomatic P. falciparum carriers written informed consent        (Fig. 1C, Ctrl), indicating signals described were <br /> as previously described (23). The study approved Ethics Com-       specific. <br /> mittee Thai Ministry Public Health Institutional Review         In order confirm exact localization RALP1 mero- <br /> Board Walter Reed Army Institute Research (WRAIR number             zoite rhoptries, used antisera RAP1, rhoptry bulb <br /> 802) (23). Human serum samples collected adults living      marker, RON4, rhoptry neck marker, test RALP1 resides in <br /> the village Kenieroba, Mali (24). The study approved ethical    compartments IFA (Fig. 1D). The IFA results showed <br /> review committees Faculty Medicine, Pharmacy, Dentistry      apical distribution RALP1, detected anti-RALP1-C2 <br /> the University Bamako (Mali) NIAID, National Institutes         antiserum, clearly RON4 (Fig. 1D, middle) and <br /> Health, Bethesda, MD (NIAID protocol number 08-I-N120). Individual            RAP1 (Fig. 1D, top). Furthermore, distribution of <br /> written informed consent obtained participants. Measure- <br />                                                                               RALP1 detected anti-RALP1-C2 antiserum overlaps of <br /> ments antibodies recombinant RALP1-C1 1:1,000-di- <br /> luted Thai Mali sera performed previously described (24). The      RALP1 detected anti-RALP1-N1 antiserum (Fig. 1D, bottom). <br /> enzyme-linked immunosorbent assays (ELISAs) replicated twice in-         IFA anti-RALP1-C1 antiserum shows RALP1 colocal- <br /> dependently.                                                                  izes RON4 (see Fig. S1 supplemental material). <br />     Statistical analysis. The Mann-Whitney U test used test            To validate precise subcellular localization of <br /> significance differences ELISA values groups, Spear-        RALP1 merozoite electron microscopy, parasites late <br /> man&#8217;s rank correlation test used test correlation ELISA    schizont stages stained RALP1-C2 specific IgG sub- <br /> and GIA values. For GIA EBA data, Kruskal-Wallis test used,       sequently secondary antibody labeled gold particles. <br /> followed Dunn&#8217;s multiple-comparison test examine differences        Gold particle signals detected neck portion the <br /> between negative-control- experimental-group values. For MIBA,            rhoptries merozoites (Fig. 1E). Together, findings estab- <br /> Fisher&#8217;s exact test Bonferroni correction performed. All statisti- <br />                                                                               lish RALP1 novel RON merozoites. <br /> cal analyses performed GraphPad Prism (GraphPad Software, <br /> San Diego, CA).                                                                   RALP1 translocates moving junction merozo- <br />                                                                               ite invasion. The data study (11) supporting direct <br /> RESULTS                                                                       role RALP1 parasite invasion limited. It clear our <br /> RALP1 localized merozoite rhoptry neck. In order                 data RALP1 expressed rhoptry neck merozoite <br /> characterize RALP1, produced recombinant RALP1 proteins                    antibodies inhibit merozoite invasion. Recent stud- <br /> (Fig. 1A <span id='am-70' about='obo:NCBITaxon_79338' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_4130 obo:NCBITaxon_4069 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91888 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71274 obo:NCBITaxon_3193'><span id='am-71' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="Codon" datatype="xsd:string"></span><span id='am-73' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-74'  ></span>codon</span> optimization. Figure 1B shows differ-              ies shown RONs Rhs tight- <br /> ent truncated RALP1 proteins, RALP1-N1 (predicted molecular                   junction proteins, suggesting specific role RONs <span id='am-65' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-66'  ></span><span id='am-67' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-69' property="rdfs:label" content="This" datatype="xsd:string"></span>this</span> <br /> mass, 13.9 kDa), RALP1-C1 (27.5 kDa), RALP1-N2 (fused                    invasion process (10, 25). To investigate role of <br /> GST, 76.0 kDa), RALP1-C2 (37.4 kDa), resolved 12.5%                  RALP1 merozoite invasion erythrocytes, performed <br /> SDS-polyacrylamide gel stained Coomassie brilliant blue              IFA analyzed localization RALP1 reference to <br /> R-250. N1, C1, C2 truncated versions RALP1 protein                 rhoptry neck bulb markers (RON4 RAP1), have <br /> were recovered supernatant fraction easily purified             shown previously localize tight junction PV, <br /> single dominant bands (Fig. 1B, arrowheads) affinity chroma-               respectively, merozoite invasion (26). By using invading <br /> tography. Since electrophoretic mobility N1, C1, C2            merozoites, showed confocal microscopic examination that <br /> proteins (Fig. 1B, arrowhead) slower, observed molecular             RALP1 colocalized RON4 moving junction through- <br /> masses higher predicted molecular masses. Even                 invasion process (Fig. 2A). Figure 2B shows RAP1 <br /> though RALP1-N2 derived multiple bands, full-length                  fluorescence seen surrounding parasite PV late <br /> band slightly faster electrophoretic mobility clearly seen           invasion stages. However, RALP1 fluorescence observed not <br /> (Fig. 1B, arrowhead). The appearance smaller bands N2 pro-              PV posterior end parasite (Fig. 2B). <br /> teins (Fig. 1B, asterisks) caused translational arrest          Taken together, observations indicate RALP1 tight- <br /> during reaction, smaller bands retain            junction protein suggest RALP1 play important <br /> GST tag N terminus (data shown). These results dem-                role merozoite invasion erythrocytes. <br /> onstrate wheat germ cell-free able translate            RALP1 does interact AMA1. To investigate whether <br /> native RALP1-encoding gene sequences produce soluble pro-                 RALP1 interacts well-known RON-AMA1 moving-junc- <br />  <br />  <br /> November 2013 Volume 81 Number 11                                                                                                        iai.asm.org 4293 <br />  Ito et al. <br />  <br />  <br />  <br />  <br />                                                                                    FIG 2 RALP1 localized moving junction invasion. RALP1 <br />                                                                                    colocalizes moving-junction marker (RON4) early through <br />                                                                                    mid late stages invasion (A). RAP1 used PV marker (B). Scale <br />                                                                                    bars represent 5 &#65533;?&#65533;m. DIC, differential interference contrast. <br />  <br />  <br />                                                                                    tion complex, performed coimmunoprecipitation experi- <br />                                                                                    ments anti-RALP1 anti-AMA1 antibodies mature- <br />                                                                                    schizont-rich parasite extracts. Immunoprecipitation either <br />                                                                                    anti-RALP1-N1 anti-RALP1-C1 antibodies, pull down <br />                                                                                    RALP1 schizont lysates, brought full-length <br />                                                                                    RALP1 protein (approximately 90 kDa) processed RALP1 <br />                                                                                    fragment (approximately 50 kDa) AMA1 RON4 (Fig. <br />                                                                                    3). The reciprocal experiment, immunoprecipitated <br />                                                                                    AMA1 anti-AMA1 antibody, pulled AMA1 <br />                                                                                    RON4 control RON-AMA1 complex not <br />                                                                                    RALP1. As negative control, proteins detected an <br />                                                                                    immunoprecipitation experiment anti-GST antibody <br />                                                                                    (Fig. 3). <br />                                                                                        RALP1 binds human erythrocytes C-terminal <br />                                                                                    region. Since RALP1 protein possesses coiled-coil do- <br />                                                                                    mains, including leucine zipper-like domain repre- <br />                                                                                    sent protein-protein interaction domain (Fig. 1A), local- <br /> FIG 1 Structure, expression, localization RALP1 P. falciparum mero- <br /> zoites. (A) Schematic primary structure RALP1. The RALP1 protein         ized moving junction (Fig. 2), investigated RALP1 <br /> consists 749 aa calculated molecular mass 87.9 kDa. The predicted     binds human erythrocytes. While preferable use native <br /> signal peptide (SP; residues 1 17), leucine zipper-like domain (LZ; residues    parasite RALP1 protein, Haase et al. (11) previously reported <br /> 511 532), coiled-coil domain (CC; residues 86 158 595 624)    RALP1 detectable parasite culture supernatants <br /> indicated. RALP1-N1 (residues 35 148), RALP1-N2 (residues 17 412), <br /> RALP1-C1 (residues 396 634), RALP1-C2 (residues 396 710) were <br />                                                                                    RALP1 appears partition insoluble fraction the <br /> expressed recombinant proteins, antibodies raised RALP1-       late-stage parasite lysate (more 50%), does not <br /> N1, RALP1-C1, RALP1-C2. (B) SDS-PAGE recombinant RALP1 pro-                 contain predicted transmembrane domain GPI anchor signal. <br /> teins. All recombinant RALP1 proteins synthesized wheat       Therefore, used recombinant GST-tagged RALP1 proteins for <br /> germ cell-free protein expression purified affinity purification <br /> columns. The fractions purified RALP1-N1 (predicted molecular mass, 13.9 <br /> kDa), RALP1-C1 (27.5 kDa), RALP1-N2 (fused GST, 76.0 kDa), and <br /> RALP1-C2 (37.4 kDa) proteins resolved 12.5% SDS-PAGE stained           probed rabbit anti-RALP1-C2 (green) mouse anti-RAP1 (rhop- <br /> Coomassie brilliant blue R-250 shown. Arrowheads indicate bands full-       try bulb marker) antibodies (top) anti-RON4 (rhoptry neck marker) (mid- <br /> length proteins. Asterisks represent bands truncated N2 proteins. (C) De-       dle) anti-RALP1-N1 (bottom) (red) antibody. Parasite nuclei stained <br /> tection RALP1 schizont lysate. Total schizont material examined       DAPI (blue). Scale bars represent 5 &#65533;?&#65533;m. DIC, differential interference <br /> Western blotting reducing condition rabbit anti-RALP1-N1 (&#65533;?&#65533;-            contrast. (E) RALP1 localization shown IEM. Two sections merozoites in <br /> N1), anti-RALP1-C1 (&#65533;?&#65533;-C1), anti-RALP1-C2 (&#65533;?&#65533;-C2) antisera. The arrow-           schizont-infected erythrocytes probed purified rabbit anti-RALP1-C2 <br /> head indicates full-length RALP1, asterisks indicate processed N-      antibody subsequently secondary antibody conjugated gold <br /> and C-terminal forms RALP1 protein. (D) RALP1 localization shown         particles shown. The black dots indicate signals gold particles local- <br /> an immunofluorescence assay. Paraformaldehyde-fixed mature schizonts               ized rhoptry necks. R, rhoptry. <br />  <br />  <br />  <br /> 4294     iai.asm.org                                                                                                                       Infection Immunity <br />                                                                                                          P. falciparum RALP1, Potential Malaria Vaccine Candidate <br />  <br />  <br />  <br />  <br />                                                                                   FIG 5 Anti-RALP1-C1 antibody invasion-inhibitory activity vitro. The <br />                                                                                   ability anti-RALP1-N1 (&#65533;?&#65533;-N1) anti-RALP1-C1 (&#65533;?&#65533;-C1) antibodies <br />                                                                                   inhibit parasite invasion erythrocytes tested one-cycle GIA. <br />                                                                                   Anti-AMA1 (&#65533;?&#65533;AMA1) anti-GST (&#65533;?&#65533;GST) antibodies used positive <br />                                                                                   negative controls, respectively. The error bars represent standard er- <br />                                                                                   rors means independent experiments. The Kruskal-Wallis test <br />                                                                                   performed, followed Dunn&#8217;s multiple-comparison test, compare <br />                                                                                   percent inhibition anti-GST anti-RALP1-N1 antibodies anti-GST <br />                                                                                   anti-RALP1-C1 antibodies. ns, significant. <br /> FIG 3 RALP1 does interact RON-AMA1 complex. Triton X-100 <br /> extracts schizont-rich parasite (PfTx extract) immunoprecipitated (IP) <br /> with rabbit serum RALP1-N1, RALP1-C1, AMA1, GST then <br /> detected Western blotting (WB) mouse antiserum RALP1-N1,          unknown. Considering erythrocyte- <br /> RALP1-C1, AMA1, RON4. Immunoprecipitation anti-GST antibody               binding epitope middle region RALP1, designed <br /> was used negative control. No bands detected anti-GST im-        RALP1-N2, overlaps N terminus RALP1-C1 17 aa <br /> munoprecipitate.                                                                  residues (i.e., N396 Q412). The erythrocyte-binding activity of <br />                                                                                   RALP1-C1 (mean &#11006; standard error mean [SEM], <br /> the EBA. The EBA performed glutathione affinity-puri-                    4.6% &#11006; 0.7%) significantly higher negative <br /> fied, GST-tagged Rh5, RALP1-N2, RALP1-C1, GST (Fig. 4A).                      control, GST (2.3% &#11006; 0.4%) (P &#65533;? 0.05). The binding activity of <br /> As shown Fig. 1C, RALP1 undergoes processing cleavage                    RALP1-N2 similar GST (Fig. 4B). These results <br /> its middle portion; however, precise cleavage site RALP1                suggest RALP1 erythrocyte-binding epitope C- <br />                                                                                   terminal region RALP1 new erythrocyte-binding pro- <br />                                                                                   tein P. falciparum. <br />                                                                                       Antibodies RALP1-C1 inhibit merozoite invasion. In or- <br />                                                                                   der test antibodies RALP1 block parasite in- <br />                                                                                   vasion, rabbit polyclonal IgGs RALP1-N1 -C1 tested <br />                                                                                   inhibition parasite growth cycle replication with <br />                                                                                   measurement parasite growth flow cytometry. When anti- <br />                                                                                   RALP1-N1, anti-RALP1-C1, anti-AMA1 (positive control), and <br />                                                                                   anti-GST (negative control) antibodies tested final con- <br />                                                                                   centration 20 mg/ml (total IgG concentration), inhibited <br />                                                                                   invasion (mean &#11006; SEM) 10% &#11006; 0.8%, 39% &#11006; 1.6%, 51% &#11006; <br />                                                                                   0.9%, 7.8% &#11006; 1.6%, respectively (Fig. 5). The invasion-inhib- <br />                                                                                   iting activity anti-RALP1-C1 antibody significantly higher <br />                                                                                   negative-control anti-GST antibody (P &#65533;? 0.001). <br />                                                                                   Anti-RALP1-N1 antibody did significant inhibition ac- <br />                                                                                   tivity, inhibition activity negligible the <br /> FIG 4 EBA recombinant RALP1. (A) SDS-PAGE recombinant pro-                anti-GST antibody. <br /> teins used EBA. All recombinant proteins synthesized         Anti-RALP1 antibodies cause merozoites aberrantly re- <br /> wheat germ cell-free protein expression GST fusion proteins         lease RAP1 IFA-based MIBA. To understand about <br /> purified affinity purification columns. The fractions purified, GST- <br /> tagged Rh5 (87 kDa), GST (27 kDa), RALP1-N2 (76 kDa), RALP1-C1 (55            mechanism invasion inhibition anti-RALP1-C1 anti- <br /> kDa) proteins resolved SDS-PAGE stained Coomassie brilliant           body GIA, performed MIBA evaluates, IFA <br /> blue R-250 shown. (B) Erythrocyte-binding activities recombinant           inspection, efficiency isolated viable, invasion- <br /> RALP1 proteins. The GST-tagged recombinant proteins incubated           competent merozoites invade erythrocytes presence an- <br /> human erythrocytes. Then recombinant proteins bound erythrocytes <br />                                                                                   tibodies. In order count parasites invading erythrocytes to <br /> were stained FITC-conjugated anti-GST antibody. The labeled erythro- <br /> cytes counted flow cytometry. As control, erythrocytes absence   distinguish pre- postinvasion merozoites, IFA was <br /> of recombinant proteins counted flow cytometry (None). The       performed DAPI labeling nuclear marker RAP1 <br /> vertical <span id='am-75' about='obo:NCBITaxon_9855' typeof='owl:Thing obo:NCBITaxon_9850 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_91561 obo:NCBITaxon_35500 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_34878 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314145 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_9845'><span id='am-76' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-77'  ></span><span id='am-78' property="rdfs:label" content="Axis" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>axis</span> represents mean percentage erythrocytes bound re-       labeling PV marker. Figure 6A shows different states of <br /> combinant protein calculated independent experiments. The error         RAP1 release merozoite invasion erythrocytes: state 1, <br /> bars indicate standard errors means independent experi- <br /> ments. The Kruskal-Wallis test performed, followed Dunn&#8217;s multiple-        RAP1 unreleased (i.e., released); state 2, RAP1 properly <br /> comparison test, compare means GST RALP1-N2 groups           released PV; state 3, RAP1 aberrantly released the <br /> the GST anti-RALP1-C1 groups. ns, significant.                            erythrocyte merozoite surface. As untreated control, per- <br />  <br />  <br /> November 2013 Volume 81 Number 11                                                                                                               iai.asm.org 4295 <br />  Ito et al. <br />  <br />  <br />  <br />  <br /> FIG 6 Anti-RALP1 antibody causes merozoites aberrantly release RAP1 in <br /> a MIBA. (A) Imaging erythrocyte-associated merozoites stained anti- <br /> RAP1 antibody DAPI analysis RAP1 localization invasion in <br /> the presence anti-RALP1-C1 antibody. Merozoites categorized into <br /> three types based RAP1 staining patterns: 1, RAP1 unreleased; 2, RAP1 <br /> properly released PV; 3, RAP1 aberrantly released erythrocyte <br /> or merozoite surface. The scale bars represent 5 &#65533;?&#65533;m. DIC, differential inter- <br /> ference contrast. (B) Stacked bar graph comparing mean percentages         FIG 7 Human sera areas Thailand Mali malaria endemic <br /> merozoites types 1 3 (shown panel A) presence anti-GST         recognize RALP1 ELISA. Probing RALP1-C1 sera P. falci- <br /> (&#65533;?&#65533;GST) anti-RALP1-C1 (&#65533;?&#65533;-C1) antibody.                                          <span id='am-83' about='obo:NCBITaxon_522859' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_469321 obo:NCBITaxon_37569 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_523180 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_7128 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-84' property="oboInOwl:hasAlternativeId" content="NCBITaxon:523222" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasRelatedSynonym" content="Parum Rothschild &amp; Jordan, 1903" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-87' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-88'  ></span><span id='am-89' property="rdfs:label" content="Parum" datatype="xsd:string"></span>parum</span>-infected asymptomatic Thai adults (Asymptomatic) naive, nonex- <br />                                                                                   posed Thai adults (Normal) (A) sera semi-immune adults in <br />                                                                                   Mali (Immune) naive, nonexposed U.S. adults (Normal) (B). P values <br /> formed MIBA incomplete culture medium                          calculated Mann-Whitney U test. The number (n) serum samples <br />                                                                                   analyzed shown. (C) Correlation anti-RAPL1-C1 antibody titers <br /> antibodies. There significant difference observed                  (logarithmic scale) vitro growth-inhibitory activities Mali semi- <br /> the total number merozoites associated untreated eryth-                   immune serum samples. The graph shows significant positive correlation <br /> rocytes associated erythrocytes treated                 antibody titers growth-inhibitory activities (Spearman&#8217;s rank <br /> anti-GST antibody (mean &#11006; SEM, 108% &#11006; 5% untreated-                        correlation, r &#11005; 0.51; 95% confidence interval, 0.14 0.75; P &#65533;? 0.01). OD, <br />                                                                                   optical density; dil., dilution. <br /> control value) anti-RALP1-C1 antibody (112% &#11006; 5%). Fur- <br /> thermore, proportion parasites unreleased RAP1 (Fig. <br /> 6A, state 1) observed presence anti-RALP1-C1 (&#65533;?&#65533;-C1)                     Sera asymptomatic Thai adults (asymptomatic) showed signif- <br /> antibody significantly different (Fisher&#8217;s exact test ad-                 icantly higher reactivity RALP1-C1 malaria-naive <br /> justed P &#11005; 0.48) observed presence anti-GST                      Thai individuals (normal) (P &#65533;? 0.01, Mann-Whitney U test) (Fig. <br /> (&#65533;?&#65533;GST) antibody (Fig. 6B, state 1).                                               7A), sera semi-immune adults Mali (Immune) <br />     However, proportion merozoites invaded (Fig.                  showed significantly higher reactivity RALP1-C1 of <br /> 6A, state 2) (measured counting properly secreted RAP1 stain-                  malaria-naive U.S. adults (normal) (P &#65533;? 0.01, Mann-Whitney U <br /> ing) significantly reduced anti-RALP1-C1 antibody com-                     test) (Fig. 7B). We evaluated functional activity purified <br /> pared anti-GST antibody (Fisher&#8217;s exact test adjusted P &#65533;?                      IgGs Malian sera P. falciparum 3D7 parasites in <br /> 0.001) (Fig. 6B, state 2). Importantly, proportion merozo-                 vitro GIA investigate correlation antibody titer <br /> ites released RAP1 aberrantly (Fig. 6A, state 3) signifi-                RAPL1-C1 vitro growth-inhibitory activity. As <br /> cantly higher presence anti-RALP1-C1 antibody                   shown Fig. 7C, significant positive correlation be- <br /> the presence control anti-GST antibody (Fisher&#8217;s exact test ad-                tween antibody titer growth-inhibitory activity (Spearman&#8217;s <br /> justed P &#65533;? 0.001) (Fig. 6B, state 3). Samples tested tripli-              rank correlation, r &#11005; 0.51; 95% confidence interval, 0.14 0.75; <br /> cate experiment. Two independent experiments                         P &#65533;? 0.01). Taken together, results suggest RALP1 is <br /> were performed (see Fig. S2 supplemental material),                    immunogenic malaria infection humans. <br /> these results agreement Fig. 6B. In short, these <br /> results suggest anti-RALP1 antibody affects merozoite inva-                  DISCUSSION <br /> sion erythrocytes merozoite attachment erythro-                     RALP1 P. falciparum previously specifically <br /> cytes.                                                                            expressed schizont stages localized rhoptry mero- <br />     Reactivity RALP1 human immune sera. Since anti-                         zoites basis IFA. It refractory gene <br /> RALP1 antibodies inhibited merozoite invasion vitro (Fig. 5                knockout attempts, suggesting RALP1 essential blood- <br /> 6B), decided investigate RALP1 exposed                    stage parasite survival; however, RAPL1 experimen- <br /> human immune P. falciparum-infected individuals                     tally characterized vaccine candidate. Here, aimed char- <br /> generates immune response. In order test presence                acterize RALP1 P. falciparum blood-stage vaccine candidate <br /> anti-RALP1 antibody sera, tested sera P. falci-                    using recombinant RALP1 expressed wheat germ cell- <br /> parum-infected asymptomatic adults western Thailand na-                    free system. <br /> <span id='am-13' about='obo:NCBITaxon_1148155' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_72037 obo:NCBITaxon_131567 obo:NCBITaxon_197562 obo:NCBITaxon_1148154 obo:NCBITaxon_197563 obo:NCBITaxon_6830 obo:NCBITaxon_33154 obo:NCBITaxon_6656 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_88770 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072'><span id='am-14' property="rdfs:label" content="Ive" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-16'  ></span><span id='am-17' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>ive</span>, nonexposed Thai adults antibodies RALP1-C1 recom-                         Our Western blotting results (Fig. 1C) agreement with <br /> binant protein ELISA (Fig. 7A) sera semi-immune                       previous report (11) primary processing events occur in <br /> adults Mali, western Africa, naive, nonexposed U.S.                   RALP1. In addition, IEM results (Fig. 1E) confirmed for <br /> adults antibodies RALP1-C1 recombinant protein (Fig. 7B).                  time RALP1 localized merozoite <br />  <br />  <br /> 4296     iai.asm.org                                                                                                                      Infection Immunity <br />                                                                                                  P. falciparum RALP1, Potential Malaria Vaccine Candidate <br />  <br />  <br />  <br /> rhoptry neck, hence, RALP1 represents novel RON. Fur-               reside outside leucine zipper-like domain (residues 511 532 <br /> thermore, IFA results obtained merozoites invading               Fig. 1A) coiled-coil domain (residues 595 624 Fig. 1A) <br /> erythrocytes (Fig. 2) revealed RALP1 translocates mov-        RALP1. These preliminary SNP analyses suggest leu- <br /> ing junction invasion RALP1 novel tight-            cine zipper-like domain coiled-coil domain RAPL1 are <br /> junction protein. Since RALP1 tight-junction protein, ex-         essential function protein. However, validate this <br /> pected RALP1 component RON-AMA1                    claim, need analysis SNPs RALP1 different field <br /> complex. However, immunoprecipitation results showed             isolates worldwide. <br /> neither AMA1 RON4 immunoprecipitated                        Overall, findings indicate RALP1 novel rhoptry <br /> RALP1, suggesting RALP1 RON-AMA1                  neck erythrocyte-binding blood-stage antigen P. falciparum <br /> complex (Fig. 3). The fact RALP1 novel tight-junction           merozoites, immunogenic antigen humans that <br /> protein (Fig. 2) erythrocyte-binding epitope C-ter-        target antibodies contribute acquired immu- <br /> minal region (Fig. 4) suggests RALP1 plays role bridging      nity falciparum malaria. Therefore, RALP1 potential <br /> protein erythrocyte surface merozoite sur-            blood-stage vaccine candidate antigen P. falciparum. This study <br /> face. However, lack transmembrane region RALP1 (Fig.          substantiates claims wheat germ cell-free system <br /> 1A) suggests RALP1 associated unknown               valuable tool identification novel malaria vaccine <br /> membrane protein anchored merozoite surface               candidates. <br /> RALP1 plays role invasion ligand, Rh proteins <br /> (10, 27). Therefore, studies required RALP1       ACKNOWLEDGMENTS <br /> receptor erythrocyte membrane possible merozoite               We grateful adults Kenieroba, Mali, donated sera, and <br /> surface proteins anchor RALP1 parasite surface.               appreciate efforts Rick Fairhurst, Mahamadou Diakite, Jennifer <br />     GIA MIBA measure capacity antibodies limit              Anderson, Saibou Doumbia facilitating availability sera. <br /> parasite growth and/or invasion P. falciparum vitro (28). Our       We grateful Jean F. Dubremetz anti-RON4 monoclonal <br /> GIA MIBA results anti-RALP1 antibodies specifi-             antibody. We thank Masachika Shudo, Integrated Center Science, <br /> cally inhibited invasion erythrocytes merozoites        Ehime University, Japan technical assistance. We thank Japa- <br /> the attachment merozoites erythrocytes. Our MIBA results            nese Red Cross Society providing human erythrocytes human <br />                                                                           plasma. <br /> clearly anti-RALP1 antibody caused merozoites to <br />                                                                               This work supported MEXT KAKENHI (23117008) and <br /> aberrantly release RAP1 merozoite erythrocyte surface         JSPS KAKENHI (23406007) Japan grant Ministry of <br /> and host cell negative control did, suggesting      Health, Labor, Welfare (H21-Chikyukibo-ippan-005), Japan. The <br /> that RALP1 plays important role correct tight-junction for-         study Malian samples supported intramural program of <br /> mation normal release RAP1 host cell. The             NIAID, NIH, PATH Malaria Vaccine Initiative. <br /> aberrant RAP1 release observed study akin previ- <br /> ously described abortive merozoite invasion anomalous              REFERENCES <br /> premature rhoptry bulb release merozoite invasion            1. WHO. 2011. World malaria report 2011. WHO Press, Geneva, Switzer- <br /> presence R1 inhibitory peptide blocks formation            land. <br />                                                                            2. Crompton PD, Pierce SK, Miller LH. 2010. Advances challenges in <br /> the RON-AMA1 complex (26). Our data consistent the <br />                                                                               malaria vaccine development. J. Clin. Invest. 120:4168 &#8211; 4178. <br /> previous finding (26) rhoptry bulb release correct tight-         3. Greenwood BM, Targett GA. 2011. Malaria vaccines new malaria <br /> junction formation occur independently triggered                 agenda. Clin. Microbiol. Infect. 17:1600 &#8211;1607. <br /> after committed merozoite attachment&#8212;an event likely initiated             4. Birkett AJ. 2010. PATH Malaria Vaccine Initiative (MVI): perspectives on <br /> by erythrocyte-binding-like/Rh proteins (26).                                 status malaria vaccine development. Hum. Vaccin. 6:139 &#8211;145. <br />                                                                            5. Cowman AF, Crabb BS. 2006. Invasion red blood cells malaria <br />     Immunoreactive antigens involved erythrocyte invasion                  parasites. Cell 124:755&#8211;766. <br /> represent potential candidates malaria vaccine (29), de-           6. Iyer J, Gruner AC, <span id='am-32' about='obo:NCBITaxon_214334' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_95222 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-33'  ></span><span id='am-34' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="Renia" datatype="xsd:string"></span>Renia</span> L, Snounou G, Preiser PR. 2007. Invasion of <br /> signing vaccine based sequences immunoreactive antigens               host cells malaria parasites: tale protein families. Mol. Micro- <br /> with minimum polymorphisms critical preventing para-                biol. 65:231&#8211;249. <br />                                                                            7. Preiser P, Kaviratne M, Khan S, Bannister L, <span id='am-108' about='obo:NCBITaxon_64828' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_7401 obo:NCBITaxon_7402 obo:NCBITaxon_131567 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_65231 obo:NCBITaxon_33154 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7400 obo:NCBITaxon_33392 obo:NCBITaxon_33317 obo:NCBITaxon_7399 obo:NCBITaxon_2759 obo:NCBITaxon_50557 obo:NCBITaxon_6960 obo:NCBITaxon_6072'><span id='am-109' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-110'  ></span><span id='am-111' property="rdfs:label" content="Jarra" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Jarra</span> W. 2000. The apical <br /> site evading vaccine-induced immunity. Not our <br />                                                                               organelles malaria merozoites: host cell selection, invasion, host immu- <br /> GIA results (Fig. 5) indicate antibodies RALP1-C1                nity immune evasion. Microbes Infect. 2:1461&#8211;1477. <br /> have invasion-inhibitory activity, immunoscreening re-             8. Alexander DL, Arastu-Kapur S, Dubremetz JF, Boothroyd JC. 2006. <br /> sults (Fig. 7) demonstrate significant correlation       Plasmodium falciparum AMA1 binds rhoptry neck protein homologous <br /> between reactivity Mali semi-immune sera                   TgRON4, component moving junction <span id='am-42' about='obo:NCBITaxon_5811' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_5810 obo:NCBITaxon_131567 obo:NCBITaxon_5809 obo:NCBITaxon_5796 obo:NCBITaxon_1280412 obo:NCBITaxon_2759 obo:NCBITaxon_75739 obo:NCBITaxon_33630 obo:NCBITaxon_423054'><span id='am-43' property="rdfs:label" content="Toxoplasma gondii" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-46'  ></span>Toxoplasma gondii</span>. <br />                                                                               Eukaryot. Cell 5:1169 &#8211;1173. <br /> RAPL1-C1 vitro growth-inhibitory activity, suggesting          9. Cao J, Kaneko O, Thongkukiatkul A, Tachibana M, Otsuki H, Gao Q, <br /> RALP1-C1 contains invasion-inhibitory epitope corre-                  Tsuboi T, Torii M. 2009. Rhoptry neck protein RON2 forms complex <br /> <span id='am-60' about='obo:NCBITaxon_8186' typeof='owl:Thing obo:NCBITaxon_186623 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_123369 obo:NCBITaxon_33154 obo:NCBITaxon_123367 obo:NCBITaxon_123368 obo:NCBITaxon_123365 obo:NCBITaxon_1489905 obo:NCBITaxon_123366 obo:NCBITaxon_1489904 obo:NCBITaxon_1489872 obo:NCBITaxon_8184 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_1489388 obo:NCBITaxon_1489341 obo:NCBITaxon_7776 obo:NCBITaxon_7898 obo:NCBITaxon_32443 obo:NCBITaxon_41665'><span id='am-61' property="rdfs:label" content="Lates" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-63'  ></span><span id='am-64' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>lates</span> immunity humans developed following natural in-                 microneme protein AMA1 Plasmodium falciparum merozoites. <br /> fection areas malaria endemic.                                    Parasitol. Int. 58:29 &#8211;35. <br />                                                                           10. Gunalan K, Gao X, Yap SS, Huang X, Preiser PR. 2013. The role the <br />     Previous preliminary single nucleotide polymorphism (SNP) <br />                                                                       <br /> </body></html>